Consumer staples ETFs can appear similar on the surface, yet differences in how they are built often lead to distinct results over time. The Fidelity MSCI Consumer Staples Index ETF (FSTA) and the Global X PureCap MSCI Consumer Staples ETF (GXPS) both provide exposure to the defensive U.S. consumer staples space. FSTA follows a capped, broad index that includes large-, mid-, and small-cap names, while GXPS uses an uncapped approach that concentrates on the sector’s largest companies. From what I see, understanding these structural choices helps clarify which fund may better align with different investor preferences around cost, diversification, and risk.
FSTA tracks the MSCI USA IMI Consumer Staples 25/50 Index. The IMI component covers large-, mid-, and small-cap U.S. consumer staples firms, and the 25/50 rules limit individual and group weightings to maintain diversification. Launched in October 2013, the fund typically holds 96–100 stocks and carries a 0.08% expense ratio. Its largest positions include WMT, COST, PG, KO, and PEP, along with PM, MO, and MDLZ. The portfolio stays focused on consumer defensive names while still offering some exposure to smaller companies within the sector. I also checked the holdings distribution using Tickeron’s AI Screener to compare sector peers.
GXPS tracks the MSCI USA Consumer Staples Index with a PureCap methodology that applies free-float market-cap weighting without company-level caps. Launched in July 2025, it holds about 33 securities and has a 0.15% expense ratio. The top 10 holdings make up roughly 80% of the fund, and it is classified as non-diversified. Largest positions mirror those in FSTA but at higher weights, including WMT, COST, PG, KO, PM, PEP, MO, CL, and MNST. This construction delivers a more concentrated bet on mega-cap leaders, which increases single-stock risk relative to broader funds.
The consumer staples sector is generally considered defensive because demand for food, beverages, household goods, and tobacco tends to remain stable across economic cycles. Recent influences include ongoing consumer price sensitivity, margin pressures from input and labor costs, and the influence of large discounters and warehouse clubs such as WMT and COST. The sector can act as a hedge during periods of higher volatility or when growth expectations moderate. Key risks involve slower volume growth, regulatory pressures in tobacco and beverages, and currency impacts for global operators.
Because the funds share many of the same top holdings, their returns have tended to move together. GXPS’s uncapped, mega-cap focus can amplify movements in names such as WMT and COST, leading to greater sensitivity to large-cap sentiment. FSTA’s capped and broader portfolio, which includes mid- and small-cap holdings, may moderate company-specific volatility and deliver a more diversified return profile. In defensive market phases both have benefited from rotation into staples, while in risk-on environments the sector has lagged. FSTA’s lower cost and wider holdings have supported more consistent positioning over time, whereas GXPS provides a more concentrated way to express the same sector view.
Considering cost efficiency, diversification, liquidity, and structural features, Tickeron’s AI currently favors FSTA over GXPS. The 0.08% expense ratio, roughly 100-name portfolio, longer track record, and larger asset base provide measurable advantages. GXPS offers a deliberate concentrated exposure to the sector’s largest names, which may suit investors seeking maximum mega-cap weighting, yet that concentration brings higher single-stock risk without an offsetting fee advantage. The assessment is based on observable structural factors rather than short-term return predictions.
In my own research I often turn to Tickeron’s AI Screener to quickly filter ETFs and stocks by industry, market cap, technical patterns, and performance metrics. It helps surface ideas and compare holdings or risk profiles more efficiently than manual methods. The tool supports customizable scans that can highlight diversification differences or cost advantages within a sector, which proved useful when reviewing these two consumer staples funds. Users can explore it at the link above to run similar sector comparisons with data-driven filters.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for FSTA moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 instances where the indicator moved out of the overbought zone. In 33 of the 36 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 68 cases where FSTA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for FSTA turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FSTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
FSTA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on November 20, 2026. You may want to consider a long position or call options on FSTA as a result. In 78 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The 10-day moving average for FSTA crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
Following a +1.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where FSTA advanced for three days, in 251 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 225 of 315 cases where FSTA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows